Healthcare · Revenue & Growth
An AI-Native Lifecycle Marketing Engagement for Medical Devices
We design, build, and run AI-native lifecycle marketing for medical device manufacturers, field service leaders, quality teams, and commercial operations. This page describes the engagement: scope, pricing, timeline, controls, and the KPIs we commit to.
Early access: we work with a small first cohort. Engagements are scoped, priced, and shipped end-to-end by our team — not referred to third parties.
In one sentence
AI-native lifecycle marketing for medical devices is a phased engagement (Discovery 2 weeks → Build 6 weeks → Run continuous) that ships a production workflow on top of QMS and CRM, moves retention by +45 pts against the medical devices baseline, and is operated under revenue & growth governance from day one.
Key facts
- Industry
- Medical Devices
- Use case
- Lifecycle Marketing
- Intent cluster
- Revenue & Growth
- Primary KPI
- retention, expansion, repeat purchase rate, activation, and unsubscribe rate
- Top benchmark
- CRM data quality (account completeness): 42% → 87% (+45 pts)
- Systems integrated
- QMS, CRM, field service platforms
- Buyer
- medical device manufacturers, field service leaders, quality teams, and commercial operations
- Risk lens
- quality management, clinical claims, product support, training accuracy, and complaint handling
- Engagement timeline
- Discovery 2 weeks → Build 6 weeks → Run continuous
- Team size
- 1 senior delivery + founder oversight
- Discovery price
- $5k · 2-week sprint
- Build price
- $15k–$22k · 6-8 weeks
Primary outcome
increase retention and expansion through personalized journeys
What we ship
segmentation model, journey builder, message library, and experiment dashboard
KPIs we report on
retention, expansion, repeat purchase rate, activation, and unsubscribe rate
Why Medical Devices teams hire us for this
Medical Devices runs on QMS, CRM, field service platforms and adjacent systems. Most automation projects in this space stop at integration — they move data, but they do not change how decisions are made. AI-native lifecycle marketing starts from the decision itself: which step needs evidence, which step needs judgment, which step can run unattended once governance is in place.
Recent industry benchmarks (Gartner, Salesforce Research) show medical devices revenue teams spend 60-70% of their week on non-selling activities. AI-native delivery targets that non-selling block first.
Industry context: Mid-market and enterprise operators face the same fundamental tradeoff: AI must compress operational cycle time while remaining auditable and integrable with existing systems of record.
Benchmarks we hit
Reference benchmarks from production deployments of lifecycle marketing in medical devices-comparable contexts. Sources noted per row. Your actuals are measured against the baseline captured in Discovery.
| Metric | Industry baseline | AI-native typical | Delta |
|---|---|---|---|
CRM data quality (account completeness) Forrester B2B Insights: human-only CRM hygiene typically degrades within 6 months | 42% | 87% | +45 pts |
Pipeline conversion (SQL → opportunity) Lift attributed to better intent scoring + faster handoff from AI to AE | 18% | 27% | +50% |
Cost per qualified meeting Includes AI infra cost, SDR time, and overhead allocation | $420 | $95 | −77% |
Benchmarks are reference values from comparable engagements and authoritative sector benchmarks. Your engagement's baseline is captured during Discovery and actuals are reported weekly during Run against that baseline.
How we operate the workflow
We do not hand over a prompt library and walk away. The Run phase is where the value compounds: weekly performance review, prompt refresh against new edge cases, retrieval index updates, escalation pattern analysis. After 6 months of Run, the workflow looks meaningfully different from day-1 deployment — and Medical Devices leadership has the data to prove the improvement.
What we build inside the workflow
Where most AI projects in medical devices stop is at the prototype that works on cherry-picked inputs. Our Build phase deliberately stresses lifecycle marketing on edge cases, adversarial inputs, malformed records, and the long tail of exceptions that real production traffic produces. The thin slice shipping to production has already passed those tests.
Reference architecture
4-layer AI-native workflow for revenue & growth
Source intake → AI orchestration → Action → Human review & quality.See the full architecture diagram for Revenue & Growth →
AI-native vs traditional approach
How a scoped AI-native engagement compares to the traditional alternatives for lifecycle marketing in medical devices.
| Dimension | Traditional (in-house build or BPO) | AI-native engagement (us) |
|---|---|---|
| Time to production | 6-12 months | 6-10 weeks (thin slice) |
| Pricing model | FTE hourly retainer or fixed staffing | Phased fixed-price (Discovery → Build → opt Run) |
| Audit / governance | Manual logs, periodic review | Versioned prompts, audit logs, reviewer queues, attestations |
| Operator throughput lift | 1.0× (baseline) | +50% |
| Cost per unit | Industry baseline | AI-native engagements deliver thin-slice production in 6-8 weeks with measurable baseline-vs-actuals reporting. |
| Exit path | Multi-quarter notice + knowledge loss | Month-to-month Run, full handover plan in Build SoW |
Traditional process automation projects cost $80-200k+ with 6-12 month payback; AI-native engagements deliver thin-slice production in 6-8 weeks with measurable baseline-vs-actuals reporting.
Engagement scope & pricing
We run this as a fixed-scope engagement with a clear commercial envelope, not an open-ended retainer.
Revenue engagement
Three phases, billed separately. You commit one phase at a time.
Phase 1 · Discovery
$5k
2-week sprint
Phase 2 · Build
$15k–$22k
6-8 weeks
Phase 3 · Run
$2k–$3k / mo
optional, hourly bank also available
~$25k–$45k typical year 1 (60% take the run option for ~6 months)
Outbound, growth, or revenue-ops workflow, integration with your CRM, weekly operating review during Run.
Discovery is the only commitment to start. After Discovery, we scope Build with a fixed price. Run is opt-in, month-to-month, no lock-in.
The 4-phase delivery model
Phase 1 · Weeks 1–2
Discovery
We map the workflow, the systems, the decisions, and the baseline metrics. Output: a scoped statement of work.
Phase 2 · Weeks 2–4
Design
We design the operating model: data access, retrieval, prompts, review queues, controls, and the KPI dashboard.
Phase 3 · Weeks 4–8
Build
We ship a production thin slice on real data, with versioned prompts, evaluation harness, and human review.
Phase 4 · Weeks 8+
Run
We run the workflow with you weekly, expand into adjacent work, and report against baseline.
Interactive ROI calculator
Estimate your AI-native ROI for lifecycle marketing
Reference inputs below are typical for medical devices teams in the revenue cluster. Adjust them to match your situation.
Projected
Current monthly cost
$24,000
AI-native monthly cost
$7,920
Annual savings
$192,960
67% cost reduction · ~468 operator-hours freed / month
Governance and risk controls
quality management, clinical claims, product support, training accuracy, and complaint handling. Those concerns are addressed by architecture, not by policy documents. We ship a control map alongside the workflow — what data sources are approved, what model versions are deployed, what reviewer queues exist, what escalation paths trigger, what attestation cadence we run. The map is on the same dashboard as the workflow metrics, not in a shared drive nobody reads.
How we report ROI
For medical devices CFOs evaluating lifecycle marketing engagements, the cleanest ROI framing is unit economics: cost per case before vs after, throughput per FTE before vs after, error rate before vs after. We instrument all three from the Discovery baseline and report against them weekly. No abstract "productivity gain" claims; concrete dollars and minutes.
Common pitfall & mitigation
The failure mode we see most often on AI-native lifecycle marketing engagements in medical devices contexts.
Volume without quality
Teams scale outbound 5× but reply rate collapses because the AI sends generic pitches
Per-prospect context retrieval (intent data + recent triggers) before any draft. Reviewer queue on first 500 sends to calibrate.
Build internally or work with us
Medical Devices teams that build successfully in-house tend to have an existing ML platform, a labelled data culture, and a product manager dedicated to the workflow. If any of those is missing, the project tends to stall at proof-of-concept. We replace those three dependencies with a scoped engagement and a senior delivery team.
What to ask us before signing
- Ask for a workflow map that shows intake, retrieval, generation, review, escalation, system updates, and measurement.
- Ask for an evaluation plan using real examples from medical devices, not only generic test prompts.
- Ask how we will move retention, expansion, repeat purchase rate, activation, and unsubscribe rate within the first 30 to 60 days.
- Ask which parts of the process remain human-owned and why.
- Ask for our exit plan: what stays with you if the engagement ends.
Recommended first project
The best first project for AI-native lifecycle marketing in medical devices is a contained workflow with enough volume to matter and enough structure to evaluate. Avoid the most politically sensitive process first. Avoid a workflow with no measurable baseline. Choose a process where we can ship a production-grade thin slice, prove adoption, and then extend the same architecture to neighboring work.
A practical target is a 30-day build followed by a 60-day operating period. In the first 30 days, we map the work, connect the minimum data sources, build the assistant, and create the review process. In the next 60 days, the system handles real volume, the team measures outcomes, and we improve the workflow weekly. By day 90, leadership knows whether to expand into adjacent work.
Frequently asked questions
How do you automate lifecycle marketing in medical devices with AI?+
We map the existing lifecycle marketing workflow inside medical devices, identify the high-volume, high-structure tasks, and build an AI agent that handles those tasks while routing low-confidence cases to a human reviewer. The build connects to your QMS, CRM, field service platforms, runs against a labelled test set, and ships behind a reviewer queue before it sees production traffic. We then operate it, measure retention, expansion, repeat purchase rate, activation, and unsubscribe rate, and improve it weekly.
What does it cost to automate lifecycle marketing for a medical devices company?+
Three phases, billed separately. Discovery sprint: $5k (2-week sprint). Build engagement: $15k–$22k (6-8 weeks). Run retainer: $2k–$3k / mo (optional, hourly bank also available). ~$25k–$45k typical year 1 (60% take the run option for ~6 months). Outbound, growth, or revenue-ops workflow, integration with your CRM, weekly operating review during Run.
What is the best AI agent for lifecycle marketing in medical devices?+
There is no single "best" off-the-shelf agent for lifecycle marketing in medical devices — the right architecture depends on your QMS setup, your data, and your risk profile. We typically combine a frontier LLM (Claude, GPT-4-class, or Gemini) with a retrieval layer over your approved sources, tool-use for QMS and CRM integrations, and a reviewer queue. We benchmark candidate models against a labelled test set during Discovery and pick the one with the best accuracy/cost ratio for your workflow.
How long does it take to deploy AI lifecycle marketing for medical devices?+
A thin-slice deployment in 2-week sprint after Discovery, with real medical devices data and real reviewers. The full Build phase runs 6-8 weeks. By day 90, retention, expansion, repeat purchase rate, activation, and unsubscribe rate is instrumented, the team has a baseline, and leadership has the data needed to decide on expansion into adjacent medical devices workflows.
What do we own, and what do you own?+
We own the workflow design, the prompts, the retrieval architecture, the evaluation harness, and weekly improvement. Your medical device manufacturers, field service leaders, quality teams, and commercial operations team owns data access, policy, exception approval, and final commercial decisions. At the end of the engagement, every prompt, eval, and config is handed over — no lock-in.
How do you measure revenue impact for lifecycle marketing in medical devices?+
We instrument retention, expansion, repeat purchase rate, activation, and unsubscribe rate from day one, paired with sector-level metrics such as service resolution time, training completion, complaint cycle time, and rep productivity. We report against baseline weekly during Run, and we publish a 90-day impact recap.
Sources we reference
The following sources inform the architecture, governance, and benchmarks we apply on medical devices engagements. Cited here so you can verify and dig deeper.
- FDA Digital Health
- Worldwide AI and Generative AI Spending Guide — IDC
- Hype Cycle for Artificial Intelligence — Gartner
- Generative AI Impact on Marketing & Sales — McKinsey
- B2B Sales Pulse Survey — Gartner for Sales
- Google Search Central: helpful, reliable, people-first content
- Google Search Central: URL structure best practices
Start the engagement
Book a discovery call for Medical Devices
Tell us about your workflow, the systems involved, and the KPI you want to move. We'll send a scoped statement of work within 5 business days.